IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin
- PMID: 9582612
IL-1 alpha, IL-1 beta and psoriasis: conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin
Abstract
A still debated question in the field of the cytokine network in psoriasis is represented by contrasting data reported on the local amount of IL-1 beta amounts, of IL-1 in this dermatosis. In fact previous studies have suggested that there were decreased Il-1 alpha amounts at the lesional level but increased nonfunctional IL-1 beta concentrations as compared to the non-lesional and normal epidermis. However, recent data suggest that IL-1 alpha and, to a lesser extent, IL-1 beta amounts, are both increased and biologically active in the epidermal cell suspension of lesional psoriatic skin as compared to those of normal skin. The data reported in the present paper show that IL-1 alpha levels are decreased in psoriatic lesional extracts of whole skin (mean 2.9 +/- 2 pg/mg) as compared to non-lesional (mean 6.7 +/- 6.2 mg/mg; p = 0.02) or normal skin (mean 13.8 +/- 9.4 pg/mg; p = 0.0002). IL-1 alpha concentrations were also significantly lower in the non-lesional skin than in normal skin (p = 0.02). In contrast, the IL-1 beta levels (mean 1.2 +/- 0.74 pg/mg were higher in the lesional samples than in the non-lesional ones (mean 0.5 +/- 0.4 pg/mg; p = 0.0004) or in normal skin (mean 0.4 +/- 0.2 pg/mg; p = 0.004). No differences in IL-1 beta levels were observed between non-lesional and normal skin (p = 0.3). In addition both IL-1 alpha and IL-1 beta are directly correlated with the disease severity and each other. Our data, extending the Il-1 determination to the whole skin, seem to confirm the previously reported findings at the epidermis level and provide new light on possible interpretation of literature discrepancies.
Similar articles
-
Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.APMIS Suppl. 1992;24:1-32. APMIS Suppl. 1992. PMID: 1567657
-
IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.J Biol Regul Homeost Agents. 1994 Oct-Dec;8(4):117-20. J Biol Regul Homeost Agents. 1994. PMID: 7660853
-
Interleukin-1: a key inflammatory mediator in psoriasis?Cytokine. 2006 Jan 21;33(2):72-8. doi: 10.1016/j.cyto.2005.12.001. Epub 2006 Feb 3. Cytokine. 2006. PMID: 16460958
-
Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.J Dermatol. 2007 Jun;34(6):367-74. doi: 10.1111/j.1346-8138.2007.00290.x. J Dermatol. 2007. PMID: 17535401 Review.
-
Transition from symptomless to lesional psoriatic skin.Clin Exp Dermatol. 1996 Sep;21(5):325-9. Clin Exp Dermatol. 1996. PMID: 9136148 Review.
Cited by
-
Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.Mediators Inflamm. 2006;2006(1):81767. doi: 10.1155/MI/2006/81767. Mediators Inflamm. 2006. PMID: 16864908 Free PMC article.
-
Interleukin-1 Gene Polymorphisms and their Relation with NFκB Expression and Histopathological Features in Psoriasis.Indian J Dermatol. 2015 Sep-Oct;60(5):432-8. doi: 10.4103/0019-5154.159630. Indian J Dermatol. 2015. PMID: 26538687 Free PMC article.
-
Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites.J Histochem Cytochem. 2008 Mar;56(3):223-31. doi: 10.1369/jhc.7A7290.2007. Epub 2007 Nov 12. J Histochem Cytochem. 2008. PMID: 17998569 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical